Effect | None |
Trial Design | Non-controlled trial |
Trial Length | 1-6 months |
Number of Subjects | 13 |
Sex | Both Genders |
Age Range | 30-44, 45-64 |
Body Types | Average |
Rose hip supplementation at 10g (low dose) or 45g (high dose) in otherwise healthy persons appeared to reduce C-reactive protein by 20-40% at the higher dose and also reduced creatinine concentrations. There was no observed effect on other parameters measured aside from chemotaxis, which was reduced by over 50% in 12/13 persons.